[
    [
        {
            "time": "",
            "original_text": "上海医药（601607）2018年三季报点评：工商齐发力，业绩再提速",
            "features": {
                "keywords": [
                    "上海医药",
                    "三季报",
                    "工商",
                    "业绩",
                    "提速"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海医药（601607）2018年三季报点评：工商齐发力，业绩再提速",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "上海医药开启“买买买”模式 123亿商誉占比3成净资产",
            "features": {
                "keywords": [
                    "上海医药",
                    "买买买",
                    "商誉",
                    "净资产"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上海医药开启“买买买”模式 123亿商誉占比3成净资产",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 9,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "上海医药:商业、工业收入稳定增长,研发投入增加影响当期业绩",
            "features": {
                "keywords": [
                    "上海医药",
                    "商业",
                    "工业",
                    "收入",
                    "研发投入",
                    "业绩"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上海医药:商业、工业收入稳定增长,研发投入增加影响当期业绩",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]